The phased deal moved forward in the spring as well, and it moved the way honest things move: slowly, with documents, and with arguments about documents, and with more documents. The first phase was the one that mattered most, because it would test whether the two companies could work together before either of them committed to a marriage. Northgate would invest a minority stake, enough to be serious and not enough to control. The two companies would fund a joint testing program, run by the Busan laboratory under its new independence structure, with results reported to a joint oversight board that included engineers from both sides and one member appointed by the Institute. The laboratory's right to reject cells would be written into the agreement, and the laboratory would report to the board, not to the product division. Hanbit's engineers would keep their safety-review authority, in writing, with a process for appealing a decision that did not depend on who was angrier.
Selma was asked, once more, to help with the Korean documents for the first phase, and once more she accepted on the same terms: she would read, translate, and explain, she would not certify technical meaning, and she would be paid for her time. The documents were different from the first packet. They were careful in a way the first packet had not been. The Korean and the English matched, not perfectly, because no two languages match perfectly, but closely, and where they did not match, the differences were noted in the margins, in both languages, by lawyers who had learned, recently, that a difference noted was a difference that could be managed, while a difference hidden was a difference that could explode.
She worked on the documents in a conference room at the law office, with Lee Ji-yeon across the table and a pot of coffee that was, this time, fresh. Lee read Selma's translations with her pencil, and she asked questions, and Selma answered them, and when Lee found a phrase in the English that was stronger than the Korean, she marked it, and the lawyers changed the English, and Selma checked the change, and the process went on, sentence by sentence, until the documents said, in both languages, what both sides meant.
"It is slower this way," Lee said, at one point, rubbing her eyes.
"It is slower," Selma agreed. "It is also the first time I have read a document from this deal and not found something hiding in it."
Lee smiled, a real smile, the kind that reaches the eyes. "That is the highest praise a document can receive from you, I think."
The first phase closed in a room that was not grand, with a table that was not polished, and with people who were not performing. Northgate's minority investment was signed, the joint testing program was funded, and the laboratory's independence was written into an agreement that both sides had read in both languages. There was no bourbon. There was no audience. There was coffee, and there were pens, and there was a moment, after the last signature, when Chairman Han stood and said, in English and then in Korean, that a beginning was not an ending, and that the work of proving a partnership would take longer than the work of announcing one.
Selma was not at the signing. She was at the restaurant, working a lunch shift, carrying plates, and when Mina Cho told her, during a break, that she had read about the deal in the business pages, Selma said, "Good. I hope it works. Hope is not a plan, but it is a place to start."
The joint testing program began, and it began with a problem, which was, Selma thought when she heard about it, exactly as it should have begun. The Busan laboratory, exercising its new independence, rejected a batch of cells that the product division had wanted to pass, because the cells had failed a test at a temperature the product division had argued was unrealistic. The product division objected. The laboratory held its ground. The joint oversight board reviewed the test, and the laboratory was right, and the batch was reworked, and the delay cost two weeks, and the reworked batch passed, and everyone involved learned, in a practical way, what independence meant when it was not just a word in an agreement.
Kim Dong-hyun told Selma about it when he called her about a Korean phrase in a testing report, and he said, "That rejection was the best thing that has happened to this deal. It proved the laboratory is real. A laboratory that never rejects anything is not a laboratory. It is a stamp."
Selma thought about that, and she wrote it in her notebook, because it was the kind of sentence that belonged in a notebook: a laboratory that never rejects anything is not a laboratory. It is a stamp. She thought about how many stamps she had seen in her life, in restaurants and in offices and in rooms where men snapped their fingers, and how rare it was to see something real.